The summer 2022 issue of the Lung-MAP Newsletter is out!

This issue reports exciting results of S1800A, introduces the newest sub-study (opened just days ago!), profiles three new representatives on the Site Coordinators Committee, and asks for your insights to help make our Lung-MAP participant population more representative of the larger population of patients with NSCLC. Read the Summer 2022 Lung-MAP Newsletter here.

Other Recent Stories

myeloMATCH: precision medicine in myeloid cancer
Oct 23, 2024
myeloMATCH precision medicine trials in myeloid leukemias open to patient enrollment across U.S. and Canada
S1826 article heading
Oct 16, 2024
Longer-term data from SWOG S1826 trial confirm nivolumab-AVD benefit in Hodgkin lymphoma